LIP
VKTX icon

Lighthouse Investment Partners’s Viking Therapeutics VKTX Stock Holding History

Lighthouse Investment Partners’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,831
Closed -$2.53M – 545
2024
Q1 		$2.53M Buy
+30,831
New +$1.37M 0.12% 204
2023
Q1 		– Sell
-30,578
Closed -$287K – 385
2022
Q4 		$287K Buy
+30,578
New +$136K 0.03% 193

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lighthouse Investment Partners's VKTX Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Viking Therapeutics (VKTX) in Q2 2024, closing a stake of 30,831 shares — an estimated $2.53M sold.

Lighthouse Investment Partners first reported a position in VKTX in Q4 2022 and held it in 2 quarters. The position peaked at $2.53M in Q1 2024. 387 funds tracked by Wall St. Rank hold VKTX as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Viking Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 30,831 Viking Therapeutics shares in Q2 2024, an estimated $2.53M.
  • Lighthouse Investment Partners first reported a position in Viking Therapeutics in Q4 2022 and held it in 2 quarters.
  • Lighthouse Investment Partners's Viking Therapeutics position peaked at $2.53M in Q1 2024.
  • 387 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.